CARBON DIOXIDE, USP (carbon dioxide) by Martin Pharmaceuticals is x-ray contrast activity [moa]. First approved in 2022.
Drug data last refreshed 17h ago · AI intelligence enriched 1mo ago
CARBON DIOXIDE, USP is an inhaled gas product approved by the FDA in April 2022 for use as an X-ray contrast agent. It functions through X-ray contrast activity mechanism to enhance radiological imaging. This is a niche diagnostic agent with specialized clinical applications in imaging procedures.
Product is in peak commercial phase with moderate competitive pressure (30%), suggesting active field presence but limited team expansion opportunities.
X-Ray Contrast Activity
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+
Extracorporeal Carbon Dioxide Removal Using PrismaLung in Reducing Ventilator Induced Lung Injury
Carbon Dioxide Investigation
Influence of Caffeine on Psychomotor Vigilance and Carbon Dioxide Tolerance During Graded Hypercapnia
RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients
Worked on CARBON DIOXIDE, USP at Martin Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Martin Pharmaceuticals is hiring 1 role related to this product
With zero linked job openings and peak lifecycle status, career opportunities on this product are currently limited and likely focused on field maintenance rather than growth roles. This is a stable, mature product suitable for professionals seeking established account management experience rather than high-growth career acceleration.